Markets Writer
Maya breaks down the day's market action for people who don't stare at a Bloomberg terminal: what moved, why, and what it means for a normal portfolio.
Reports of repeated Trump calls to Fed Chair Kevin Warsh raise a credibility question, though no evidence shows rate-policy pressu...
SpaceX rose as its first lockup expired, while large options trades added bullish exposure with defined but substantial downside r...
The July jobs report arrives Friday at 8:30 a.m. ET, with economists expecting modest hiring and a steady unemployment rate.
UWMC shares dropped about 40% intraday after UWM reported a Q2 loss, halted its common dividend and outlined a $2.05 billion capit...
AppLovin’s Q2 sales grew 53%, but a small revenue miss and below-consensus EBITDA outlook reset expectations for investors.
Jim Cramer’s Charitable Trust plans to exit Honeywell Aerospace at a roughly 15% loss after the new public company reduced 2026 ta...
The reported EU request puts visa-free Schengen travel at risk for five Caribbean nations, but no suspension has been imposed.
JPMorgan’s CEO said borrowing across markets is high and could amplify a shock, while stopping short of predicting a systemic cris...
Honeywell Aerospace missed second-quarter forecasts, cut its outlook and blamed supply constraints, leading CNBC’s Investing Club...
Bank of America CEO Brian Moynihan said the fund’s forced stock sale is a warning about lofty valuations and borrowed money.
Eli Lilly raised its 2026 revenue forecast after second-quarter sales rose 48%, led by Mounjaro and Zepbound despite lower prices.
CVS raised its 2026 outlook after reporting a second-quarter beat, while Aetna’s medical benefit ratio fell to 87.4%.